Evaluation of asymmetric dimethylarginine, arginine, and carnitine metabolism in pediatric sepsis

Pediatric Critical Care Medicine

Volumn 13, Issue 4, 2012, Pages

  Weiss, Scott L ^a   Haymond, Shannon ^c   Ranaivo, Hantamalala Ralay ^b   Wang, Deli ^d   De Jesus, Victor R ^e   Chace, Donald H ^f,g   Wainwright, Mark S ^a,b  

^a Divisions of Critical Care   (United States)

^b Neurology   (United States)

^c Department of Pathology and Laboratory Medicine ^*  (United States)

^d CHILDREN'S MEMORIAL HOSPITAL   (United States)

^e CHILDREN S MEMORIAL RESEARCH CENTER   (United States)

^f CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^g PEDIATRIX MEDICAL GROUP   (United States)

Author keywords

Arginine; Carnitine; Intensive care units; Nitric oxide; Nitric oxide synthase; Pediatric; Sepsis

Indexed keywords

ACYLCARNITINE; ARGININE; CARNITINE; CITRULLINE; DIMETHYLARGININE; INTERLEUKIN 8; ORNITHINE; UNCLASSIFIED DRUG;

ADOLESCENT; AMINO ACID METABOLISM; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE MARKER; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME ACTIVITY; FEMALE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; SEPSIS; SEPTIC SHOCK;

ADOLESCENT; ARGININE; CARNITINE; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES; SEPSIS;

EID: 84864283156     PISSN: 15297535     EISSN: 19473893     Source Type: Journal    
DOI: 10.1097/PCC.0b013e318238b5cd     Document Type: Article

References (49)

1. Watson RS, Carcillo JA, Linde-Zwirble WT, et al: The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med 2003; 167: 695-701 (Pubitemid 36801744)
2. Vincent JL, Zhang H, Szabo C, et al: Effects of nitric oxide in septic shock. Am J Respir Crit Care Med 2000; 161: 1781-1785 (Pubitemid 30418107)
3. Moncada S, Higgs A: The l-arginine-nitric oxide pathway. N Engl J Med 1993; 329: 2002-2012 (Pubitemid 24015045)
4. Avontuur JA, Tutein Nolthenius RP, van Bodegom JW, et al: Prolonged inhibition of nitric oxide synthesis in severe septic shock: A clinical study. Crit Care Med 1998; 26: 660-667 (Pubitemid 28201411)
5. Broccard A, Hurni JM, Eckert P, et al: Tissue oxygenation and hemodynamic response to NO synthase inhibition in septic shock. Shock 2000; 14: 35-40
6. Lopez A, Lorente JA, Steingrub J, et al: Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock. Crit Care Med 2004; 32: 21-30 (Pubitemid 38125559)
7. Trzeciak S, Cinel I, Phillip Dellinger R, et al: Resuscitating the microcirculation in sepsis: The central role of nitric oxide, emerging concepts for novel therapies, and challenges for clinical trials. Acad Emerg Med 2008; 15: 399-413
8. Argaman Z, Young VR, Noviski N, et al: Arginine and nitric oxide metabolism in critically ill septic pediatric patients. Crit Care Med 2003; 31: 591-597 (Pubitemid 36232960)
9. Luiking YC, Poeze M, Ramsay G, et al: Reduced citrulline production in sepsis is related to diminished de novo arginine and nitric oxide production. Am J Clin Nutr 2009; 89: 142-152
10. Davis JS, Anstey NM: Is plasma arginine concentration decreased in patients with sepsis? A systematic review and meta-analysis. Crit Care Med 2011; 39: 380-385
11. Kalil AC, Danner RL: l-Arginine supplementation in sepsis: Beneficial or harmful? Curr Opin Crit Care 2006; 12: 303-308 (Pubitemid 44078141)
12. Tran CT, Leiper JM, Vallance P: The DDAH/ADMA/NOS pathway. Atheroscler Suppl 2003; 4: 33-40 (Pubitemid 38234493)
13. Davis JS, Darcy CJ, Yeo TW, et al: Asymmetric dimethylarginine, endothelial nitric oxide bioavailability and mortality in sepsis. PLoS One 2011; 6: e17260
14. Nijveldt RJ, Teerlink T, Van Der Hoven B, et al: Asymmetrical dimethylarginine (ADMA) in critically ill patients: High plasma ADMA concentration is an independent risk factor of ICU mortality. Clin Nutr 2003; 22: 23-30 (Pubitemid 36193177)
15. O'Dwyer MJ, Dempsey F, Crowley V, et al: Septic shock is correlated with asymmetrical dimethyl arginine levels, which may be influenced by a polymorphism in the dimethylarginine dimethylaminohydrolase II gene: A prospective observational study. Crit Care 2006; 10: R139
16. Richir MC, van Lambalgen AA, Teerlink T, et al: Low arginine/asymmetric dimethylarginine ratio deteriorates systemic hemodynamics and organ blood flow in a rat model. Crit Care Med 2009; 37: 2010-2017
17. Sydow K, Munzel T: ADMA and oxidative stress. Atheroscler Suppl 2003; 4: 41-51 (Pubitemid 38234494)
18. Fink MP: Bench-to-bedside review: Cytopathic hypoxia. Crit Care 2002; 6: 491-499 (Pubitemid 35414580)
19. Sharma S, Smith A, Kumar S, et al: Mechanisms of nitric oxide synthase uncoupling in endotoxin-induced acute lung injury: Role of asymmetric dimethylarginine. Vascul Pharmacol 2009; 52: 182-190
20. Sud N, Wells SM, Sharma S, et al: Asymmetric dimethylarginine inhibits HSP90 activity in pulmonary arterial endothelial cells: Role of mitochondrial dysfunction. Am J Physiol Cell Physiol 2008; 294: C1407-1418
21. Sharma S, Sud N, Wiseman DA, et al: Altered carnitine homeostasis is associated with decreased mitochondrial function and altered nitric oxide signaling in lambs with pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2008; 294: L46-L56 (Pubitemid 351380317)
22. Wainwright MS, Kohli R, Whitington PF, et al: Carnitine treatment inhibits increases in cerebral carnitine esters and glutamate detected by mass spectrometry after hypoxia-ischemia in newborn rats. Stroke 2006; 37: 524-530 (Pubitemid 43732018)
23. Goldstein B, Giroir B, Randolph A: International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 2005; 6: 2-8
24. Gaies MG, Gurney JG, Yen AH, et al: Vasoactive-inotropic score as a predictor of morbidity and mortality in infants after cardiopulmonary bypass. Pediatr Crit Care Med 2010; 11: 234-238
25. Slater A, Shann F, Pearson G: PIM2: A revised version of the Paediatric Index of Mortality. Intensive Care Med 2003; 29: 278-285 (Pubitemid 36384419)
26. Leteurtre S, Martinot A, Duhamel A, et al: Validation of the Paediatric Logistic Organ Dysfunction (PELOD) score: Prospective, observational, multicentre study. Lancet2003; 362: 192-197
27. Engelberger RP, Teta D, Henry H, et al: Hemodialysis acutely reduces the plasma levels of asymmetric dimethylarginine (ADMA) without reversing impaired nitric oxide dependent vasodilation. Clin Sci (Lond) 2009; 117: 293-303
28. Wang S, Vicente FB, Miller A, et al: Measurement of arginine derivatives in pediatric patients with chronic kidney disease using high-performance liquid chromatography-tandem mass spectrometry. Clin Chem Lab Med 2007; 45: 1305-1312 (Pubitemid 47557069)
29. Chace DH, Pons R, Chiriboga CA, et al: Neonatal blood carnitine concentrations: Normative data by electrospray tandem mass spectometry. Pediatr Res 2003; 53: 823-829 (Pubitemid 36504728)
30. Benedetto C, Marozio L, Neri I, et al: Increased l-citrulline/l-arginine plasma ratio in severe preeclampsia. ObstetGynecol 2000; 96: 395-399
31. Morris CR, Kato GJ, Poljakovic M, et al: Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. JAMA 2005; 294: 81-90 (Pubitemid 41002842)
32. Billecke SS, Kitzmiller LA, Northrup JJ, et al: Contribution of whole blood to the control of plasma asymmetrical dimethylarginine. Am J Physiol Heart Circ Physiol 2006; 291: H1788-1796 (Pubitemid 44497685)
33. Nijveldt RJ, Teerlink T, van Leeuwen PA: The asymmetrical dimethylarginine (ADMA)-multiple organ failure hypothesis. Clin Nutr 2003; 22: 99-104 (Pubitemid 36193187)
34. Boger RH, Maas R, Schulze F, et al: Elevated levels of asymmetric dimethylarginine (ADMA) as a marker of cardiovascular disease and mortality. Clin Chem Lab Med 2005; 43: 1124-1129 (Pubitemid 41581972)
35. Brouns R, Marescau B, Possemiers I, et al: Dimethylarginine levels in cerebrospinal fluid of hyperacute ischemic stroke patients are associated with stroke severity. Neurochem Res 2009; 34: 1642-1649
36. Schulze F, Lenzen H, Hanefeld C, et al: Asymmetric dimethylarginine is an independent risk factor for coronary heart disease: Results from the multicenter Coronary Artery Risk Determination investigating the Influence of ADMA Concentration (CARDIAC) study. Am Heart J 2006; 152: 493 e491-e498
37. Yeo TW, Lampah DA, Tjitra E, et al: Increased asymmetric dimethylarginine in severe falciparum malaria: Association with impaired nitric oxide bioavailability and fatal outcome. PLoS Pathog 2010; 6: e1000868
38. Wilcken DE, Sim AS, Wang J, et al: Asymmetric dimethylarginine (ADMA) in vascular, renal and hepatic disease and the regulatory role of l-arginine on its metabolism. Mol GenetMetab 2007; 91: 309-317; discussion 318 (Pubitemid 47043511)
39. Mittermayer F, Namiranian K, Pleiner J, et al: Acute Escherichia coli endotoxaemia decreases the plasma l-arginine/asymmetrical dimethylarginine ratio in humans. Clin Sci (Lond) 2004; 106: 577-581 (Pubitemid 38797569)
40. Palm F, Onozato ML, Luo Z, et al: Dimethylarginine dimethylaminohydrolase (DDAH): Expression, regulation, and function in the cardiovascular and renal systems. Am J Physiol Heart Circ Physiol 2007; 293: H3227-H3245 (Pubitemid 350230862)
41. Ito A, Tsao PS, Adimoolam S, et al: Novel mechanism for endothelial dysfunction: Dysregulation of dimethylarginine dimethylaminohydrolase. Circulation 1999; 99: 3092-3095 (Pubitemid 29289071)
42. Zoccali C, Maas R, Cutrupi S, et al: Asymmetric dimethyl-arginine (ADMA) response to inflammation in acute infections. Nephrol Dial Transplant 2007; 22: 801-806 (Pubitemid 46351688)
43. Nijveldt RJ, Teerlink T, van Guldener C, et al: Handling of asymmetrical dimethylarginine and symmetrical dimethylarginine by the rat kidney under basal conditions and during endotoxaemia. Nephrol Dial Transplant 2003; 18: 2542-2550 (Pubitemid 37483787)
44. Iapichino G, Umbrello M, Albicini M, et al: Time course of endogenous nitric oxide inhibitors in severe sepsis in humans. Minerva Anestesiol 2010; 76: 325-333
45. Jia YX, Pan CS, Yang JH, et al: Altered l-arginine/nitric oxide synthase/nitric oxide pathway in the vascular adventitia of rats with sepsis. Clin Exp Pharmacol Physiol 2006; 33: 1202-1208 (Pubitemid 44923909)
46. Bune AJ, Shergill JK, Cammack R, et al: l-Arginine depletion by arginase reduces nitric oxide production in endotoxic shock: An electron paramagnetic resonance study. FEBS Lett 1995; 366: 127-130
47. Groeneveld PH, Kwappenberg KM, Langermans JA, et al: Relation between pro- and anti-inflammatory cytokines and the production of nitric oxide (NO) in severe sepsis. Cytokine 1997; 9: 138-142 (Pubitemid 27116889)
48. Neilly IJ, Copland M, Haj M, et al: Plasma nitrate concentrations in neutropenic and non-neutropenic patients with suspected septicaemia. Br J Haematol 1995; 89: 199-202
49. Cardounel AJ, Cui H, Samouilov A, et al: Evidence for the pathophysiological role of endogenous methylarginines in regulation of endothelial NO production and vascular function. J Biol Chem 2007; 282: 879-887 (Pubitemid 47076535)